We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHAK icon
1101
Shake Shack
SHAK
$2.87B
$24.7M 0.01%
291,534
+1,286
+0.4% +$99.8K
YELP icon
1102
Yelp
YELP
$1.41B
$24.7M 0.01%
756,000
+408,844
+118% +$10.7M
WSO icon
1103
Watsco Inc
WSO
$13.6B
$24.7M 0.01%
108,856
-18,349
-14% -$4.22M
SSB icon
1104
SouthState Bank Corp
SSB
$10.5B
$24.7M 0.01%
341,041
+2,612
+0.8% +$172K
QGEN icon
1105
Qiagen
QGEN
$8.72B
$24.6M 0.01%
439,502
+11,435
+3% +$610K
ATR icon
1106
AptarGroup
ATR
$8.61B
$24.6M 0.01%
179,379
+820
+0.5% +$102K
TPR icon
1107
Tapestry
TPR
$32.8B
$24.6M 0.01%
789,969
-33,642
-4% -$852K
BILI icon
1108
Bilibili
BILI
$7.84B
$24.5M 0.01%
286,348
+92,048
+47% +$5.39M
ASH icon
1109
Ashland
ASH
$3.5B
$24.5M 0.01%
309,470
+185,678
+150% +$14M
CRUS icon
1110
Cirrus Logic
CRUS
$6.26B
$24.5M 0.01%
298,175
-16,012
-5% -$1.2M
DNLI icon
1111
Denali Therapeutics
DNLI
$3.97B
$24.4M 0.01%
291,862
-36,489
-11% -$2.21M
UGI icon
1112
UGI
UGI
$7.33B
$24.4M 0.01%
699,054
+41,420
+6% +$1.45M
MMSI icon
1113
Merit Medical Systems
MMSI
$5.32B
$24.4M 0.01%
439,845
-4,485
-1% -$231K
HCAT icon
1114
Health Catalyst
HCAT
$128M
$24.4M 0.01%
560,626
+31,191
+6% +$1.15M
OSIS icon
1115
OSI Systems
OSIS
$3.89B
$24.4M 0.01%
261,540
-5,408
-2% -$462K
CARG icon
1116
CarGurus
CARG
$3.47B
$24.4M 0.01%
767,724
+359,598
+88% +$8.88M
HAE icon
1117
Haemonetics
HAE
$4B
$24.3M 0.01%
204,796
+59,959
+41% +$6.45M
BBL
1118
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$24.3M 0.01%
+458,176
New +$21M
MTSI icon
1119
MACOM Technology Solutions
MTSI
$23.7B
$24.3M 0.01%
441,291
+134,404
+44% +$5.73M
ATRC icon
1120
AtriCure
ATRC
$2.11B
$24.2M 0.01%
434,578
-1,737
-0.4% -$75.1K
FN icon
1121
Fabrinet
FN
$20.1B
$24.1M 0.01%
311,070
+30,285
+11% +$2.06M
HQY icon
1122
HealthEquity
HQY
$8.75B
$24.1M 0.01%
346,104
-8,244
-2% -$513K
SAIL
1123
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$24.1M 0.01%
453,166
-122,037
-21% -$5.72M
LADR
1124
Ladder Capital
LADR
$1.24B
$24.1M 0.01%
2,463,197
+81,821
+3% +$695K
TPTX
1125
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$24M 0.01%
196,635
+7,736
+4% +$848K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.